Found 8 matching trials
Anti-Cytokine Therapy for Hemodialysis InflammatION
PHASE2Anti-Cytokine Therapy for Hemodialysis InflammatION (ACTION) is a phase II ...
Location
The George Washington University
Capecitabine-based Chemoradiotherapy in Combination With the IL-1 Receptor Antagonist Anakinra for Rectal Cancer Patients
PHASE1The ACO/ARO/AIO-21 investigator-driven, open-labeled, phase I drug re-purpo...
Location
University Hospital Goethe University Frankfurt
SCIL-1Ra in COVID-19 Feasibility & PK/PD
PHASE2The current COVID-19 pandemic is a worldwide healthcare crisis. Of concern ...
Location
Manchester Univesity NHS Foundation Trust
BLOC-ICH: Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage
PHASE2This trial will help inform the development of a new treatment for intracer...
Location
Salford Royal NHS Foundation Trust
Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia
PHASE2The current study is an exploratory, phase IIa randomized clinical trial (R...
Location
4th Department of Internal Medicine, "Attikon" University Hospital, National and Kapodistrian University of Athens, Medical School
A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Acute Gouty Arthritis
PHASE2The purpose of this study is to evaluate how anakinra relieves pain for pat...
Location
University of Alabama at Birmingham
Effects of Interleukin-1 Receptor Antagonism on Hyperandrogenemia in Women With Polycystic Ovary Syndrome
PHASE2A prospective, interventional, open-label, single-arm, proof-of-concept stu...
Location
University Hospital Basel Endocrinology, Diabetes and Metabolism
IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes
PHASE2A prospective, randomized, mixed double- and single-blinded, placebo-contro...
Location
University Hospital Basel